Full Press Release Details
BridgeBio Pharma Shares Positive Results Of Single-arm Phase 3 Study Of Acoramidis In Japanese Patients With ATTR-CM.
BBIO
BridgeBio Pharma Shares Positive Results Of Single-arm Phase 3 Study Of Acoramidis In Japanese Patients With ATTR-CM
Key Takeaway: BridgeBio Pharma Shares Positive Results Of Single-arm Phase 3 Study Of Acoramidis In Japanese Patients With ATTR-CM